(1)
Molecular Docking and Dynamics Analysis to Reveal the Therapeutic Potential of Dostarlimab Against Novel Immune Targets in Liver Cancer. IJBB 2024, 61 (11), 740-755. https://doi.org/10.56042/ijbb.v61i11.12051.